JPWO2019214715A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019214715A5 JPWO2019214715A5 JP2020556289A JP2020556289A JPWO2019214715A5 JP WO2019214715 A5 JPWO2019214715 A5 JP WO2019214715A5 JP 2020556289 A JP2020556289 A JP 2020556289A JP 2020556289 A JP2020556289 A JP 2020556289A JP WO2019214715 A5 JPWO2019214715 A5 JP WO2019214715A5
- Authority
- JP
- Japan
- Prior art keywords
- meloxicam
- composition
- acid
- water
- adjuster
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 33
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 claims description 29
- 229960001929 meloxicam Drugs 0.000 claims description 29
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 6
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 5
- 230000036592 analgesia Effects 0.000 claims description 5
- 201000008482 osteoarthritis Diseases 0.000 claims description 5
- 230000002980 postoperative effect Effects 0.000 claims description 5
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 24
- 239000003002 pH adjusting agent Substances 0.000 claims 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 9
- 239000003960 organic solvent Substances 0.000 claims 8
- 239000002904 solvent Substances 0.000 claims 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- 239000007864 aqueous solution Substances 0.000 claims 6
- 239000012669 liquid formulation Substances 0.000 claims 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 4
- 229920000858 Cyclodextrin Polymers 0.000 claims 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 4
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 230000002378 acidificating effect Effects 0.000 claims 3
- 229960003194 meglumine Drugs 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims 2
- -1 15-hydroxystearic acid-polyethylene Chemical group 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 2
- 235000011054 acetic acid Nutrition 0.000 claims 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 2
- 235000010323 ascorbic acid Nutrition 0.000 claims 2
- 239000011668 ascorbic acid Substances 0.000 claims 2
- 229960005070 ascorbic acid Drugs 0.000 claims 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 2
- 150000002170 ethers Chemical class 0.000 claims 2
- 239000001530 fumaric acid Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 238000010253 intravenous injection Methods 0.000 claims 2
- 239000004310 lactic acid Substances 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- 239000001630 malic acid Substances 0.000 claims 2
- 235000011090 malic acid Nutrition 0.000 claims 2
- 239000011259 mixed solution Substances 0.000 claims 2
- 229940068886 polyethylene glycol 300 Drugs 0.000 claims 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 239000011975 tartaric acid Substances 0.000 claims 2
- 235000002906 tartaric acid Nutrition 0.000 claims 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 2
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 239000001116 FEMA 4028 Substances 0.000 claims 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 claims 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims 1
- 229960004853 betadex Drugs 0.000 claims 1
- 239000004359 castor oil Substances 0.000 claims 1
- 235000019438 castor oil Nutrition 0.000 claims 1
- 229940097362 cyclodextrins Drugs 0.000 claims 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 235000011087 fumaric acid Nutrition 0.000 claims 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 claims 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 claims 1
- 150000002303 glucose derivatives Chemical class 0.000 claims 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 235000011167 hydrochloric acid Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- FYFFGSSZFBZTAH-UHFFFAOYSA-N methylaminomethanetriol Chemical compound CNC(O)(O)O FYFFGSSZFBZTAH-UHFFFAOYSA-N 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
- 235000019799 monosodium phosphate Nutrition 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 235000011007 phosphoric acid Nutrition 0.000 claims 1
- 229920001983 poloxamer Polymers 0.000 claims 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 239000008213 purified water Substances 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 229910000029 sodium carbonate Inorganic materials 0.000 claims 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 1
- 239000001488 sodium phosphate Substances 0.000 claims 1
- 229910000162 sodium phosphate Inorganic materials 0.000 claims 1
- 235000011008 sodium phosphates Nutrition 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims 1
- 239000008215 water for injection Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810451076 | 2018-05-11 | ||
CN201810450456 | 2018-05-11 | ||
CN201810451076.4 | 2018-05-11 | ||
CN201810450456.6 | 2018-05-11 | ||
PCT/CN2019/086424 WO2019214715A1 (fr) | 2018-05-11 | 2019-05-10 | Composition de méloxicam, sa préparation et son procédé de préparation et son utilisation |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2021521212A JP2021521212A (ja) | 2021-08-26 |
JPWO2019214715A5 true JPWO2019214715A5 (fr) | 2023-07-07 |
JP7374501B2 JP7374501B2 (ja) | 2023-11-07 |
Family
ID=68467257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020556289A Active JP7374501B2 (ja) | 2018-05-11 | 2019-05-10 | メロキシカム組成物、製剤及びその製造方法と応用 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210106591A1 (fr) |
EP (1) | EP3777862A4 (fr) |
JP (1) | JP7374501B2 (fr) |
KR (1) | KR20210007951A (fr) |
CN (3) | CN116327960A (fr) |
WO (1) | WO2019214715A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10881663B2 (en) * | 2018-03-08 | 2021-01-05 | Baudax Bio, Inc. | Method of treating pain in elderly patients with mild renal impairment |
CN112823786A (zh) * | 2019-11-21 | 2021-05-21 | 北京泰德制药股份有限公司 | 一种含有美洛昔康的药物组合物及应用 |
CN114569553B (zh) * | 2022-02-28 | 2023-06-09 | 沈阳信达泰康医药科技有限公司 | 一种不含高分子稳定剂的美洛昔康纳米分散体系 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10030345A1 (de) * | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen |
US20020035107A1 (en) * | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10161077A1 (de) * | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
CN1493292A (zh) | 2003-01-04 | 2004-05-05 | 沈阳药科大学 | 以hpcd作增溶剂及稳定剂的美洛昔康液体制剂及其制备方法 |
US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
DE102004021281A1 (de) | 2004-04-29 | 2005-11-24 | Boehringer Ingelheim Vetmedica Gmbh | Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin |
AU2005313365A1 (en) | 2004-12-06 | 2006-06-15 | Janssen Pharmaceutica N.V. | Oral suspension comprising meloxicam |
WO2008062274A2 (fr) * | 2006-11-20 | 2008-05-29 | Cadila Pharmaceuticals Limited | Préparations pharmaceutiques de ains à administration parentérale |
TR200809200A1 (tr) * | 2008-12-01 | 2009-12-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Meloksikam içeren farmasötik formülasyonlar |
KR101873500B1 (ko) | 2009-04-24 | 2018-08-02 | 아이슈티카 피티와이 리미티드 | 생물학적 활성 물질의 용해 프로파일 개선방법 |
CA2763456C (fr) | 2009-05-27 | 2017-10-24 | Alkermes Pharma Ireland Limited | Reduction de l'agregation a l'origine de paillettes dans des compositions a base d'un principe actif nanoparticulaire |
IN2012DN03157A (fr) | 2009-10-12 | 2015-09-18 | Boehringer Ingelheim Vetmed | |
US20110218191A1 (en) | 2010-03-03 | 2011-09-08 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long term-treatment of kidney disorders in cats |
JP6050564B2 (ja) | 2010-03-11 | 2016-12-21 | テイカ製薬株式会社 | フィルム状製剤 |
CN102908310A (zh) | 2012-11-02 | 2013-02-06 | 青岛康地恩药业股份有限公司 | 一种犬、猫用治疗类风湿性关节炎的美洛昔康注射液 |
CN103110575B (zh) | 2013-03-07 | 2014-11-05 | 宁夏康亚药业有限公司 | 一种美洛昔康滴眼液及其制备方法和应用 |
CN103690480A (zh) * | 2013-12-18 | 2014-04-02 | 吉林修正药业新药开发有限公司 | 治疗类风湿性关节炎、骨性关节炎的美洛昔康注射液及其制备方法 |
-
2019
- 2019-05-10 US US17/044,767 patent/US20210106591A1/en active Pending
- 2019-05-10 CN CN202310332895.8A patent/CN116327960A/zh active Pending
- 2019-05-10 CN CN202310332893.9A patent/CN116327959A/zh active Pending
- 2019-05-10 EP EP19800759.3A patent/EP3777862A4/fr active Pending
- 2019-05-10 JP JP2020556289A patent/JP7374501B2/ja active Active
- 2019-05-10 CN CN201910390430.1A patent/CN110464846B/zh active Active
- 2019-05-10 WO PCT/CN2019/086424 patent/WO2019214715A1/fr unknown
- 2019-05-10 KR KR1020207028041A patent/KR20210007951A/ko unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6517725B2 (ja) | アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法 | |
JP6444548B2 (ja) | スルホアルキルエーテルシクロデキストリン組成物 | |
KR101202649B1 (ko) | 소듐 디클로페낙 및 β-시클로덱스트린을 포함하는 주사용약학 조성물 | |
JP2007536228A (ja) | セルトラリンおよびスルホアルキルエーテルシクロデキストリンを含有するテイストマスク製剤 | |
JP2018076533A (ja) | アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法 | |
MX2008013407A (es) | Composiciones de bolo iv premezcladas, listas para uso y metodos de uso. | |
EA034430B1 (ru) | Жидкая водная фармацевтическая композиция с консервантами, содержащая этерифицированные производные циклодекстрина | |
WO2001041757A1 (fr) | Composition pharmaceutique contenant de la cyclodextrine | |
JP4399161B2 (ja) | 非経口投与用のドロネダロン医薬組成物 | |
JP7374501B2 (ja) | メロキシカム組成物、製剤及びその製造方法と応用 | |
JPWO2019214715A5 (fr) | ||
JP2006508917A (ja) | メスナを有する、オキサザホスホリンの液体安定性組成物 | |
KR20220123388A (ko) | 알킬화된 사이클로덱스트린 조성물 및 이의 제조 및 사용 방법 | |
AU2005230380B2 (en) | Cyclodextrin inclusions complexes of pyrimidine-2,4,6-triones | |
EP1525884B1 (fr) | Preparations liquides aqueuses et preparations liquides aqueuses photostabilisees | |
JP2023544122A (ja) | アルキル化シクロデキストリン組成物ならびにその調製方法および使用方法 | |
KR20230134092A (ko) | 안질환 예방 또는 치료용 약학 조성물 | |
JPH0256427A (ja) | 動脈外科を補完するためのトロンボキサン受容体拮抗剤の使用 |